Inactive Instrument
Oncorus, Inc. Stock
Stocks
ONCR
US68236R1032
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -3.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gina Balderas
COO | Chief Operating Officer | - | - |
| Corporate Officer/Principal | - | - | |
Chris German
AUD | Comptroller/Controller/Auditor | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/6/23 A | Other | Chief Executive Officer | 61,085 | 0.2341% | ||
| 12/28/22 A | Deerfield Management Co. LP
| Sell | Company | 336,235 | 1.2945% | |
| 12/22/22 A | Deerfield Management Co. LP
| Sell | Company | 73,384 | 0.2825% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.08% | +869.23% | - | - | 3.29M | ||
| -0.62% | +0.50% | +33.92% | +60.07% | 64.38B | ||
| +0.35% | +3.04% | +12.64% | +83.62% | 56.16B | ||
| +0.53% | +2.55% | +13.90% | +104.77% | 54.16B | ||
| -2.81% | -3.95% | +22.72% | +48.57% | 45.33B | ||
| -0.33% | -3.12% | +17.62% | +117.27% | 42.25B | ||
| +0.55% | +1.93% | +229.73% | +928.00% | 40.78B | ||
| +3.27% | +47.40% | +110.44% | +94.92% | 33.8B | ||
| +1.22% | -1.39% | +13.92% | +46.95% | 32.25B | ||
| -1.29% | -1.72% | +21.00% | -6.85% | 23.57B | ||
| Average | -0.23% | +4.72% | +52.88% | +164.14% | 43.63B | |
| Weighted average by Cap. | +0.01% | +3.64% | +49.57% | +162.47% |
Employees
64
















